Eastwood Begin Period Cash Flow from 2010 to 2024
| EBM Stock | CAD 0.75 0.05 6.25% |
Begin Period Cash Flow | First Reported 2013-10-31 | Previous Quarter 6 K | Current Value 8.2 K | Quarterly Volatility 922.1 K |
Check Eastwood Bio-Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eastwood Bio-Medical's main balance sheet or income statement drivers, such as Interest Expense of 34 K, Selling General Administrative of 858.4 K or Selling And Marketing Expenses of 2.8 K, as well as many indicators such as Price To Sales Ratio of 116, Dividend Yield of 0.0 or Days Sales Outstanding of 48.53. Eastwood financial statements analysis is a perfect complement when working with Eastwood Bio-Medical Valuation or Volatility modules.
Eastwood | Begin Period Cash Flow |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.